Abstract
Purpose
To review the current genetic aspects of tuberous sclerosis complex.
Methods
Review of the literature.
Results
Tuberous sclerosis complex (TSC), a long known childhood-onset monogenic disorder, characterized by hamartoma formation affecting mainly the brain, heart, kidney, lung, and skin, is associated with a high morbidity burden and risk of a reduced life span. The identification of TSC1 and TSC2, as tumor suppressor genes causative of the disorder, led to the elucidation of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway and its pivotal role in the pathogenesis of hamartoma formation. This knowledge was translated into standard clinical practice with the discovery of rapamycin, and additional analogues, as inhibitors of mTORC1.
Conclusion
Next-generation sequencing was proven to be fundamental to drive research of tumorigenesis in TSC, hopefully leading to new therapeutic options in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Peron A, Sing KA, Northrup H (2018) Genetics, genomics, and genotype–phenotype correlations of TSC: insights for clinical practice. Am J Med Genet 178C:281–290
Brigo F, Lattanzi S, Trink E, Nardone R, Bragazzi NL, Ruggieri M, Martiniand M, Walusinski O (2018) First descriptions of tuberous sclerosis by Désiré-Magloire Bourneville (1840–1909). Neuropathology 38:577–582
Northrup H, Krueger DA, on behalf of the international tuberous sclerosis complex consensus group (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:243–254
Roach ES, Gomez MR, Northrup H (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13:624–628
Krueger DA, Northrup H on behalf of the international tuberous sclerosis complex consensus group (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:255–265
Kingswood JC, Bissler JJ, Budde K, Hulbert J, Guay-Woodford L, Sampson JR, Sauter M, Cox J, Patel U, Elmslie F, Anderson C, Zonnenberg BA (2012) Review of the tuberous sclerosis renal guidelines from the 2012 consensus conference: current data and future study. Nephron 134:51–58
Samueli S, Abraham K, Dressler A, Groeppel G, Jonak C, Muehlebner A, Prayer D, Reitner A, Feucht M, Pädiatrisches TSC-Zentrum Wien (2015) Tuberous sclerosis complex: new criteria for diagnostic work-up and management. Wien Klin Wochenschr 127:619–630
Henske EP, Jozwiak S, Kingswood JC, Sampson JR, Theile EA (2016) Tuberous sclerosis complex. Nat Rev 2:1–18
McEneaney LJ, Tee AR (2019) Finding a cure for tuberous sclerosis complex: from genetics through to targeted drug therapies. Adv Genet 103:91–118
Cheadle JP, Reeve PR, Sampson JR, Kwiatkowski DJ (2000) Molecular genetic advances in tuberous sclerosis. Hum Genet 107:97–114
Schwartz RA, Fernandez G, Kotulska K, Jozwiak J (2007) Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 57:189–202
Curatolo P, Jozwiak S, Nabbout R, on behalf of the participants of the TSC Consensus Meeting for SEGA and Epilepsy Management in TSC (2012) Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. EJPN 16:582–586
Farach LS, Gibson WT, Sparagana SP, Nellist M, Stumpel CTR, Hietala M, Friedman E, Pearson DA, Creighton SP, Wagemans A, Segel R, Ben-Shalom E, Au KS, Northrup H (2017) TSC2 c.1864C>T variant associated with mild cases of tuberous sclerosis complex. Am J Med Genet A 173A:771–775
Lam HC, Nijmeh J, Henske EP (2017) New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol 241:219–225
Giannikou K, Lasseter KD, Grevelink JM, Tyburczy ME, Dies KA, Zhu Z, Hamieh L, Wollison BM, Thorner AR, Ruoss SJ, Thiele EA, Sahin M, Kwiatkowski DJ (2019) Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission. Genet Med 21:2639–2643
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, on behalf of the ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424
French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Berkowitz N, Voi M, Peyrard S, Pelov D, Franz DN (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388:2153–2163
Schubert-Bast S, Rosenow F, Kleinb KM, Reif PS, Kieslich M, Strzelczyk A (2019) The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: current evidence and future perspectives. Epilepsy Behav 91:94–98
Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Voi M, Fan J, Vaury A, Pelov D, French JA (2018) Everolimus for treatment-refractory seizures in TSC: extension of a randomized controlled trial. Neurol Clin Pract 8(5):412–420
Rendtorff DN, Bjerregaard B, Frodin M, Kjaergaard S, Hove H, Skovby F, The Danish Tuberous Sclerosis Group, Brøndum-Nielsen K, Schwartz M (2005) Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations. Hum Mutat 26(4):374–383
Bénit P, Bonnefont JP, Mostefa AK, Francannet C, Munnich A, Ray PF (2001) Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis. Prenat Diagn 21:279–283
Treichel AM, Kwiatkowski DJ, Moss J, Darling TN (2020) A diagnostic algorithm for enhanced detection of mosaic tuberous sclerosis complex in adults. Br J Dermatol 182:218–250
Caban C, Khan N, Hasbani DM, Crino PB (2017) Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet 10:1–8
Author information
Authors and Affiliations
Contributions
The author contributed to all aspects of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest
Ethics approval
Not applicable
Consent to participate
Not applicable
Consent for publication
Not applicable
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Marom, D. Genetics of tuberous sclerosis complex: an update. Childs Nerv Syst 36, 2489–2496 (2020). https://doi.org/10.1007/s00381-020-04726-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04726-z